Compare Hims and Hers Health Inc (HIMS) vs ProShares UltraPro Short QQQ ETF (SQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs ProShares UltraPro Short QQQ ETF — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while ProShares UltraPro Short QQQ ETF trades at $32.95 (market cap $2.23B). The key difference: Hims and Hers Health Inc is far larger — about 2.9× ProShares UltraPro Short QQQ ETF's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, ProShares UltraPro Short QQQ ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and ProShares UltraPro Short QQQ ETF for 12 Days on average.
| HIMS | SQQQ | |
|---|---|---|
Market Cap | $6.55B | $2.23B |
Volume | 14,842,814 | 60,436,012 |
Sector | Health | Leveraged / Inverse |
52-Week High | $62.76 | $89.43 |
52-Week Low | $14.52 | $31.83 |
Typical Hold Time | 21 Days | 12 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
SQQQ (ProShares UltraPro Short QQQ) is trading at $33.37, up 4.02% today amid bearish technical signals. The ETF shows strong bearish momentum with moving averages indicating sell pressure while oscillators remain neutral. Recent news highlights SQQQ's role as a hedging tool against Nasdaq 100 declines, with financial media noting its strategic use during tech sector volatility.
The outlook remains tied to Nasdaq 100 performance, with SQQQ positioned to benefit from further tech weakness. Key risks include timing sensitivity and decay from daily rebalancing. Investment opportunity exists for tactical hedging but requires careful risk management due to the leveraged inverse structure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About ProShares UltraPro Short QQQ ETF
SQQQ is a leveraged inverse ETF that seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the Nasdaq-100 Index. It is a tactical trading tool designed for sophisticated investors to profit from or hedge against declines in large-cap technology and growth stocks. Due to its daily reset and the effects of compounding, it is intended for short-term use and carries significant risk if held during periods of high market volatility.
Read more on SQQQ →
